Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Operating Expenses (2017 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Other Operating Expenses over the past 11 years, most recently at -$1.1 million for Q2 2025.

  • For Q2 2025, Other Operating Expenses rose 54.54% year-over-year to -$1.1 million; the TTM value through May 2025 reached $409000.0, down 98.96%, while the annual FY2025 figure was $409000.0, 98.96% down from the prior year.
  • Other Operating Expenses for Q2 2025 was -$1.1 million at Lifecore Biomedical, Inc. \De\, down from -$600000.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $21.0 million in Q1 2024 and troughed at -$26.1 million in Q2 2022.
  • A 5-year average of $319538.5 and a median of $200000.0 in 2023 define the central range for Other Operating Expenses.
  • On a YoY basis, Other Operating Expenses climbed as much as 350.0% in 2024 and fell as far as 700.0% in 2024.
  • Year by year, Other Operating Expenses stood at $9.3 million in 2021, then crashed by 77.29% to $2.1 million in 2022, then surged by 881.97% to $20.7 million in 2023, then crashed by 94.2% to $1.2 million in 2024, then tumbled by 190.92% to -$1.1 million in 2025.
  • Business Quant data shows Other Operating Expenses for LFCR at -$1.1 million in Q2 2025, -$600000.0 in Q1 2025, and $1.2 million in Q4 2024.